Seroprevalence of antibodies to measles, mumps, and rubella among Thai population: Evaluation of measles/MMR immunization programme

Journal of Health, Population and Nutrition

Volumn 27, Issue 1, 2009, Pages 80-86

  Tharmaphornpilas, Piyanit ^a   Yoocharean, Pornsak ^a   Rasdjarmrearnsook, Aim orn ^a   Theamboonlers, Apiradee ^b   Poovorawan, Yong ^b  

^a MINISTRY OF PUBLIC HEALTH   (Thailand)

^b CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Antibodies; Immunization; Measles; Measles vaccine; MMR vaccine; Mumps; Rubella; Seroepidemiologic studies; Seroprevalence; Thailand; Vaccination

Indexed keywords

RUBELLA;

MEASLES MUMPS RUBELLA VACCINE; MEASLES VACCINE; MUMPS VACCINE; RUBELLA ANTIBODIES; RUBELLA VACCINE; VACCINE; VIRUS ANTIBODY;

ADOLESCENT; AGE; ARTICLE; BLOOD; CHILD; EPIDEMIOLOGY; FEMALE; HUMAN; IMMUNOLOGY; MALE; MEASLES; MEASLES VIRUS; MUMPS; MUMPS VIRUS; PREVENTIVE HEALTH SERVICE; RUBELLA; THAILAND; TIME;

ADOLESCENT; AGE FACTORS; ANTIBODIES, VIRAL; CHILD; FEMALE; HUMANS; IMMUNIZATION PROGRAMS; MALE; MEASLES; MEASLES VACCINE; MEASLES VIRUS; MEASLES-MUMPS-RUBELLA VACCINE; MUMPS; MUMPS VACCINE; MUMPS VIRUS; RUBELLA; RUBELLA VACCINE; SEROEPIDEMIOLOGIC STUDIES; THAILAND; TIME FACTORS; VACCINES, COMBINED;

EID: 63149183905     PISSN: 16060997     EISSN: None     Source Type: Journal    
DOI: 10.3329/jhpn.v27i1.3320     Document Type: Article

References (31)

1. History of immunization in Thailand. In: Chokpaiboonkit K, Trishnananda M, Chunsuttiwat S, Tharmaphornpilas P, editors. Vaccine and immunization 2007. Nonthaburi: Ministry of Public Health, 2007:13-24.
2. Thailand. Department of Disease Control. Bureau of General Communicable Diseases. Vaccine coverage survey, Thailand 2003. Nonthaburi: Ministry of Public Health, 2004:25-31.
3. Thailand. Department of Disease Control. Bureau of General Communicable Diseases. Vaccine coverage survey among students grade 1 and 6, 2004. Nonthaburi: Ministry of Public Health, 2005:16-9.
4. Centers for Disease Control and Prevention. Progress toward global measles control and elimination, 1990-1996. MMWR 1997;46:893-7.
5. Centers for Disease Control and Prevention. Update: global measles control and mortality reduction-worldwide 1991-2001. MMWR 2003;52:471-5.
6. Disease surveillance. Nonthaburi: Bureau of Epidemiology, 2007. (http://203.157.15.6/d506/selectds.php, accessed on 30 April 2007).
7. Thailand. Department of Disease Control. Bureau of Epidemiology. Annual epidemiological surveillance report 2004. Nonthaburi: Ministry of Public Health, 2005:89-94.
8. Chongsrisawat V, Yoocharoen P, Theamboonlers A, Tharmaphornpilas P, Warinsathien P, Sinlaparatsamee S et al. Hepatitis B seroprevalence in Thailand: 12 years after hepatitis B vaccine integration into the national expanded programme on immunization. Trop Med Int Health 2006;11:1496-502.
9. Chatproedprai S, Chongsrisawat V, Chatchatee P, Theamboonlers A, Yoocharoen P, Warinsathien P et al. Declining trend in the seroprevalence of infection with hepatitis A virus in Thailand. Ann Trop Med Parasitol 2007;101:61-8.
10. Ratnam S, Gadag V, West R, Burris J, Oates E, Stead F, Bouilianne N. Comparison of commercial enzyme immunoassay kits with plaque reduction neutralization test for detection of measles virus antibody. J Clin Microbiol 1995;33:811-5.
11. Chen RT, Markowitz LE, Albrecht P, Stewart JA, Mofenson LM, Preblud SR et al. Measles antibody: reevaluation of protective titers. J Infect Dis 1990;162:1036-42.
12. Skendzel LP. Rubella immunity. Defining the level of protective antibody. Am J Clin Pathol 1996;106:170-4.
13. Thailand. Permanent Secretary Office. Division of Epidemiology. Annual epidemiological surveillance report 1991. Bangkok: Ministry of Public Health, 1992:190-7.
14. Thailand. Permanent Secretary Office. Division of Epidemiology. Annual epidemiological surveillance report 1996. Bangkok: Ministry of Public Health, 1997:235-42.
15. de Melker H, Pebody RG, Edmunds WJ, Lévy-Bruhl D, Valle M, Rota MC, Salmaso S et al. The seroepidemiology of measles in Western Europe. Epidemiol Infect 2001;126:249-59.
16. Saipan P, Jiwapaisarnpong T, Pattanadilok S, Loyha Y, Janggajit T. Measles antibody in the children in Ubon Ratchathani province. J Med Assoc Thai 2001;84:500-6.
17. Techasena W, Sriprasert P, Pattamadilok S, Wongwacharapipoon P. Measles antibody in mothers and infant 0-2 years and response to measles vaccine at the age of 9 and 18 months. J Med Assoc Thai 2007;90:106-12.
18. Lohleka S, Pirom N, Issaraprasat S, Patarakijvanich N, Jayavasu C, Chatiyanonda K. Measles vaccination in Thai children. Ramathibodi Med J 1982;5:245-52.
19. Ndikuyeze A, Munoz A, Stewart J, Modlin J, Heymann D, Herrmann KL et al. Immunogenicity and safety of measles vaccine in ill African children. Int J Epidemiol 1988;17:448-55.
20. Black FL, Berman LL, Libel M, Reichelt CA, Pinheiro FP, Travassos da Rosa A et al. Inadequate immunity to measles in children vaccinated at an early age: effect of revaccination. Bull World Health Organ 1984;62:315-9.
21. Huang LM, Lee CY, Hsu CY, Huang SS, Kao CL, Wu FF et al. Effect of monovalent measles and trivalent measles-mumps-rubella vaccine at various ages and concurrent administration with hepatitis B vaccine. Pediatr Infect Dis J 1990;9:461-5.
22. Jutasamit K, Nantawas S, Promkor U. Measles vaccine efficiency in 2 Mong villages, Nan province. Thai Wkly Dis Surveil Rep 1994;25:681-9.
23. Raxkshib P, Cham-on S, Reaunkong J, Pongpisitson P, Tummakitkun N, Sombat S. Measles vaccine effectiveness at Bonthong district of Chonburi. Thai J Health Sci 1995;4:13-8.
24. Huntra N, Baichit B, Sungkachart L. Efficacy of measles vaccine in epidemic areas of Ayutthaya. Thai Commun Dis J 1996;22:144-9.
25. Lertpiriyasuwat C, Kanlayanpotporn J, Deeying J, Kijphati R, Thepsoontorn S. Measles outbreak in an orphanage, Bangkok, Thailand September-October 2000. J Med Assoc Thai 2002;85:653-7.
26. Chotwichain S. Measles epidemic in Suratthani 2002. Nonthaburi: Thailand Field Epidemiology Training Program, 2004:1-27. (PhD dissertation).
27. Christenson B, Böttiger M. Measles antibody: comparison of long-term vaccination titres, early vaccination titres and naturally acquired immunity to and booster effects on the measles virus. Vaccine 1994;12:129-33.
28. Krugman S. Further-attenuated measles vaccine: characteristics and use. Rev Infect Dis 1983;5:477-81.
29. Thailand. Ministry of Public Health. Department of Disease Control. Outbreak list. Nonthaburi: Bureau of Epidemiology, 2008. (http://203.157.15.4/invest/outbreak/outbreaklist.php, accessed on 14 May 2008).
30. Kim SS, Han HW, Go U, Chung HW. Sero-epidemiology of measles and mumps in Korea: impact of the catch-up campaign on measles immunity. Vaccine 2004;23:290-7.
31. Chiu HH, Lee CY, Chih TW, Lee PI, Chang LY, Lin YJ, Hsu CM et al. Seroepidemiological study of measles after the 1992 nationwide MMR revaccination program in Taiwan. J Med Virol 1997;51:32-5.